Skip to main content

February 2018

 

 

academics

 

Clinical research courses

HOW WOULD A NATION LIKE INDIA BEAR EXPENSES OF INSULINS AND NON-INSULIN ANTI-DIABETICS IN COMING YEARS?

ABOUT AUTHOR
Amit Gangwal
Director, Arogya Retail
Indore, MP, India
Gangwal.amit@gmail.com

Perhaps insulin is the only molecule or medicinal molecule which has helped scientist/s to claim Nobel Prize at least for 3 times. Frederick Banting & J.J.R. Macleod were awarded with Nobel Prize in 1923 for the discovery of insulin. Another Nobel, in 1958, went into the account of British molecular biologist Frederick Sanger for determining the primary structure of insulin. Rosalyn Sussman Yalow was selected for Nobel of 1977 for the development of the radioimmunoassay for insulin.

In a significant development for Indian patients requiring treatment for structural or congenital heart disease and defects, Admedus Limited  in partnership with Syncronei Medical India Pvt Ltd, and supported by the Australian Trade and Investment Commission (Austrade), is pleased to introduce its ground-breaking and clinically-superior ADAPT® technology in India.